Grupo International

GRPI

Medical - Pharmaceuticals · Healthcare

Price

$0.00

+0.00 (+0.00%)

Market Cap

$1,043

Winston Score

–

No score yet — Winston is napping.

We couldn’t gather enough financial data to score this stock reliably.

Share count rising — dilution

+1.5% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 9.8M (2006) → 10.0M (2010)

Grupo International Inc. (GRPI) is a small pharmaceutical company focused on developing and distributing medical and health-related products. The company has operated in areas including generic drugs and healthcare distribution, targeting patients and healthcare providers as its main customers. It is a micro-cap company in the broader pharmaceutical industry.

Grupo International generates revenue through product sales and distribution agreements, though its financial results have been minimal, with effectively no reported revenue or profit margins. The company is very small, with a market cap near zero, which places it in the category of shell or early-stage companies that carry significant uncertainty. The primary risk for investors is that the company has shown little evidence of active commercial operations, making it difficult to assess its actual business viability or path to generating consistent revenue.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

Revenue data limited

EPS Growth

+0.0% YoY

YoY Growth Rate

Slow EPS growth

R&D Spend

$22,111/ year

→ Flat (+5% vs prior year)

Steady R&D investment year-over-year

Insider Activity

70.3%ownership

→ Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~15 months

$1,911 cash & investments

Adequate runway but may need to raise capital within 2 years

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

N/A

—

Data not available

Operating Margin

N/A

—

Data not available

ROCE

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

N/A

—

Data not available

EPS YoY

N/A

—

Data not available

EPS Consistency

0/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

—

Data not available

FCF Margin

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

N/A

—

Data not available

Interest Cover

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

—

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial